Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Molecular Immunology Unit,
Institut Jules Bordet
Karen Willard-Gallo has not added Biography.
If you are Karen Willard-Gallo and would like to personalize this page please email our Author Liaison for assistance.
Identification of three NFAT binding motifs in the 5'-upstream region of the human CD3gamma gene that differentially bind NFATc1, NFATc2, and NF-kappa B p50.
The Journal of biological chemistry Dec, 2002 | Pubmed ID: 12374807
Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elements.
Journal of immunology (Baltimore, Md. : 1950) May, 2005 | Pubmed ID: 15879122
6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.
Haematologica Jun, 2005 | Pubmed ID: 15951288
Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome.
Experimental hematology Oct, 2005 | Pubmed ID: 16219537
Pertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes.
European journal of immunology Jul, 2006 | Pubmed ID: 16783847
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner.
Molecular cancer therapeutics Dec, 2006 | Pubmed ID: 17148762
Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing.
Virology journal , 2007 | Pubmed ID: 17822534
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.
Blood Oct, 2009 | Pubmed ID: 19608752
State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.
Current gene therapy Dec, 2009 | Pubmed ID: 20021330
CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.
The Journal of clinical investigation Jul, 2013 | Pubmed ID: 23778140
Tumor-infiltrating follicular helper T cells: The new kids on the block.
Oncoimmunology Oct, 2013 | Pubmed ID: 24244900
Université Libre de Bruxelles
Soizic Garaud*,1,2,
Chunyan Gu-Trantien*,1,2,
Jean-Nicolas Lodewyckx1,2,
Anaïs Boisson1,2,
Pushpamali De Silva1,2,
Laurence Buisseret1,2,
Edoardo Migliori1,2,
Myriam Libin3,
Céline Naveaux1,2,
Hugues Duvillier1,4,
Karen Willard-Gallo1,2
1Molecular Immunology Unit, Université Libre de Bruxelles,
2Institut Jules Bordet, Université Libre de Bruxelles,
3Institut d'Immunologie Médicale, Université Libre de Bruxelles,
4Flow Cytometry Core Facility, Université Libre de Bruxelles
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten